➀ Researchers at the University of Ottawa have developed a new contrast agent for IV-OCT, using gold superclusters (AuSC) to enhance imaging clarity. ➁ The team coated the AuSC with a special polymer for stability and targeted imaging. ➂ The new agent, AuSC@(13FS)2, binds to P-selectin and improves IV-OCT imaging, potentially leading to personalized heart disease treatments.
Related Articles
- Pure Quantum State Without Cooling Effort3 months ago
 - Novel Nanoplatform Overcomes Treatment Resistance in Bladder Cancer5 months ago
 - Loughborough University Physicists Create ‘The World’s Smallest Violin’ Using Nanotechnology5 months ago
 - Rapid Biomimetic Nanovaccine for Personalized Cancer Therapy5 months ago
 - Startup aims to 3D print chips and cut production costs by 90% — nanoprinter operates at wafer scale6 months ago
 - Self-Aligned Carbon Nanotube Phototransistors for Infrared Detection7 months ago
 - Optimizing Cobalt Thin Films for Data Storage: Plasma-Assisted Surface Modification7 months ago
 - Manufacturing Nanomaterials in Space to Treat Disease on Earth7 months ago
 - IHP and Nagoya University, Japan, Jointly Develop Next-Generation Semiconductor Technologies7 months ago
 - IHP and University of Nagoya, Japan, Collaborate on Next-Generation Semiconductor Technologies7 months ago